Your Article Summary
See Latest ArticlesReduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome
Clinical Pharmacology & Therapeutics, 08/18/06
Rachele Berria, MD, et al. - Thiazolidinediones have gained widespread use for the treatment of type 2 diabetes mellitus and other insulin resistance states, including polycystic ovary syndrome (PCOS). In thiazolidinedione-treated patients a small reduction in hemoglobin and hematocrit levels often is observed, and this generally has been attributed to fluid retention
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
Expert Opinion in Pharmacotherapy, 12/09/09
Complications and side-effects of foam sclerotherapy
Phlebology, 12/09/09
Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review
Headache: The Journal of Head and Face Pain, 12/08/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Developments in factor Xa inhibitors for the treatment of thromboembolic disorders
Medicinal Research Reviews, 12/09/09
Monitored anesthesia care (MAC) sedation: clinical utility of fospropofol
Therapeutics and Clinical Risk Management, 12/09/09
Pharmacotherapy of diabetic foot osteomyelitis
Expert Opinion in Pharmacotherapy, 12/09/09